loading
전일 마감가:
$1.39
열려 있는:
$1.39
하루 거래량:
657.84K
Relative Volume:
0.24
시가총액:
$99.55M
수익:
$391.70K
순이익/손실:
$-52.34M
주가수익비율:
-1.8733
EPS:
-0.75
순현금흐름:
$-45.92M
1주 성능:
-12.44%
1개월 성능:
-23.86%
6개월 성능:
+332.94%
1년 성능:
+22.89%
1일 변동 폭
Value
$1.39
$1.42
1주일 범위
Value
$1.34
$1.63
52주 변동 폭
Value
$0.2425
$2.01

Ovid Therapeutics Inc Stock (OVID) Company Profile

Name
명칭
Ovid Therapeutics Inc
Name
전화
212-776-4381
Name
주소
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
Name
직원
23
Name
트위터
@OvidRx
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
OVID's Discussions on Twitter

OVID을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
OVID
Ovid Therapeutics Inc
1.40 98.84M 391.70K -52.34M -45.92M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
424.69 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.02 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
446.18 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
825.84 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
182.89 40.44B 447.02M -1.18B -868.57M -6.1812

Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-09 개시 Oppenheimer Outperform
2025-08-08 재개 B. Riley Securities Buy
2024-06-18 다운그레이드 Oppenheimer Outperform → Perform
2024-04-30 개시 B. Riley Securities Buy
2024-04-29 개시 H.C. Wainwright Buy
2024-04-05 개시 Wedbush Outperform
2023-12-21 개시 BTIG Research Buy
2023-10-13 개시 Oppenheimer Outperform
2021-04-20 다운그레이드 Cantor Fitzgerald Buy → Neutral
2021-03-03 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2020-12-02 다운그레이드 Citigroup Buy → Neutral
2020-12-02 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2019-09-04 개시 RBC Capital Mkts Outperform
2018-04-20 개시 Ladenburg Thalmann Buy
모두보기

Ovid Therapeutics Inc 주식(OVID)의 최신 뉴스

pulisher
05:19 AM

Can trapped investors hope for a rebound in Ovid Therapeutics Inc.Rate Cut & Low Drawdown Momentum Trade Ideas - newser.com

05:19 AM
pulisher
01:19 AM

Using flow based indicators on Ovid Therapeutics Inc.Trade Entry Report & Verified Swing Trading Watchlist - newser.com

01:19 AM
pulisher
Nov 02, 2025

What MACD trends signal for Ovid Therapeutics Inc. (1OT) stockJuly 2025 Rallies & Low Drawdown Momentum Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What analysts say about Ovid Therapeutics Inc 1OT stockSector Leadership Analysis & Low Risk Capital Appreciation - earlytimes.in

Nov 02, 2025
pulisher
Nov 02, 2025

How Ovid Therapeutics Inc. (1OT) stock correlates with oil markets2025 Price Action Summary & Fast Entry and Exit Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Combining machine learning predictions for Ovid Therapeutics Inc.Watch List & Technical Buy Zone Confirmation - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Visual analytics tools that track Ovid Therapeutics Inc. performanceM&A Rumor & Risk Managed Investment Entry Signals - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is Ovid Therapeutics Inc. stock a safe haven assetWeekly Gains Summary & Scalable Portfolio Growth Methods - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Long term hold vs stop loss in Ovid Therapeutics Inc.July 2025 Spike Watch & Real-Time Volume Spike Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Ovid Therapeutics Inc. (1OT) stock protected from inflation2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

How strong is Ovid Therapeutics Inc. stock balance sheetJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Short Interest in Ovid Therapeutics (NASDAQ:OVID) Grows By 463.2% - MarketBeat

Oct 29, 2025
pulisher
Oct 28, 2025

Ovid Therapeutics (OVID) Price Target Increased by 22.06% to 4.23 - Nasdaq

Oct 28, 2025
pulisher
Oct 28, 2025

Quarterly Recap: How Ovid Therapeutics Inc. stock compares to industry benchmarksEarnings Summary Report & Weekly Sector Rotation Insights - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

OVID PRE 14A: approvals for Series B conversion and warrants - Stock Titan

Oct 28, 2025
pulisher
Oct 27, 2025

OVID special meeting to approve PIPE share issuances and 315M authorization - Stock Titan

Oct 27, 2025

Ovid Therapeutics Inc (OVID) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Ovid Therapeutics Inc 주식 (OVID) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Rona Jeffrey A
CBFO
Feb 26 '25
Sale
0.56
3,902
2,185
67,973
ALEXANDER MARGARET A.
President and COO
Jan 27 '25
Buy
0.73
6,810
4,971
34,935
$37.52
price up icon 0.03%
$93.16
price down icon 0.32%
$28.84
price up icon 0.79%
$104.30
price up icon 0.20%
biotechnology ONC
$313.33
price up icon 0.97%
$184.11
price down icon 2.65%
자본화:     |  볼륨(24시간):